A Study to Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies

by | Jul 22, 2026 | Clinical Trials | 0 comments

​ Conditions: Acute Myeloid Leukemia; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndrome Acute Myeloid Leukemia

Interventions: Drug: S241656; Drug: Posaconazole

Sponsors: Servier

Not yet recruiting Conditions: Acute Myeloid Leukemia; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndrome Acute Myeloid Leukemia
Interventions: Drug: S241656; Drug: Posaconazole
Sponsors: Servier
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *